279 - Why Europe’s AstraZeneca Situation is Reassuring—COVID-19 Vaccine Safety Update with Dan Salmon

<p>Last week, parts of Europe suspended the use of AstraZeneca’s COVID-19 vaccine after a few vaccinated individuals reported dangerous blood clots. Johns Hopkins vaccine safety expert <strong>Dan Salmon</strong> talks with <strong>Stephanie Desmon</strong> about the situation and why it’s reassuring in terms of vaccine safety monitoring, and how these are questions that “can and will be answered by science.” Note: This conversation was recorded on March 17. Since then, the European Medicines Agency has concluded that the vaccine’s benefits outweigh the risks.</p>